Combination therapy in hormone-refractory prostate cancer

被引:0
作者
Daniel P. Petrylak
机构
关键词
Prostate Cancer; Hydrocortisone; Docetaxel; Mitoxantrone; Estramustine;
D O I
10.1007/s11912-001-0033-4
中图分类号
学科分类号
摘要
引用
收藏
页码:453 / 453
相关论文
共 50 条
[41]   New targeted therapies in hormone-refractory prostate cancer [J].
Oudard, Stephane ;
Banu, Eugeniu ;
Scotto, Florian ;
Beuzeboc, Philippe ;
Guyader, Charlotte ;
Medioni, Jacques .
BULLETIN DU CANCER, 2007, 94 :F62-F68
[42]   Therapeutic options for hormone-refractory prostate cancer in 2007 [J].
Hadaschik, Boris A. ;
Gleave, Martin E. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (05) :413-419
[43]   Targeted therapeutic approaches for hormone-refractory prostate cancer [J].
Stavridi, Flora ;
Karapanagiotou, Eleni M. ;
Syrigos, Kostas N. .
CANCER TREATMENT REVIEWS, 2010, 36 (02) :122-130
[44]   Endothelin and skeletal metastases in hormone-refractory prostate cancer [J].
Hamdy, FC .
EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) :15-19
[45]   Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer [J].
Malhotra, Manav ;
Dhingra, Richa ;
Sharma, Tina ;
Deep, Aakash ;
Narasimhan, Balasubramanian ;
Phogat, Priyanka ;
Sharma, Prabodh Chander .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (06) :915-920
[46]   Role of Chemotherapy in Nonmetastatic Hormone-Refractory Prostate Cancer [J].
Bellmunt, Joaquim .
EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (05) :448-452
[47]   A long and winding road: the role of chemotherapy for hormone-refractory prostate cancer [J].
Higgins, G. S. ;
Stewart, G. D. ;
McNeill, S. A. ;
McLaren, D. B. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (12) :1964-1965
[48]   Oral Chemotherapy in the Treatment of Hormone-Refractory Prostate Cancer [J].
Kenneth J. Pienta ;
Jeffrey M. Kamradt ;
David C. Smith .
Drugs, 1999, 58 :127-131
[49]   Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer [J].
Vordos, D ;
Paule, B ;
Vacherot, F ;
Allory, Y ;
Salomon, L ;
Hoznek, A ;
Yiou, R ;
Chopin, D ;
Abbou, CC ;
de la Taille, A .
BJU INTERNATIONAL, 2004, 94 (04) :524-527
[50]   In vivo Evidence of γ-Tocotrienol as a Chemosensitizer in the Treatment of Hormone-Refractory Prostate Cancer [J].
Yap, W. N. ;
Zaiden, N. ;
Luk, S. Y. ;
Lee, D. T. W. ;
Ling, M. T. ;
Wong, Y. C. ;
Yap, Y. L. .
PHARMACOLOGY, 2010, 85 (04) :248-258